Stay updated on Clinical Trial: Delandistrogene in Duchenne Muscular Dystrophy
Sign up to get notified when there's something new on the Clinical Trial: Delandistrogene in Duchenne Muscular Dystrophy page.

Latest updates to the Clinical Trial: Delandistrogene in Duchenne Muscular Dystrophy page
- ChecktodayNo Change Detected
- Check8 days agoChange DetectedThe page now shows that recruitment is closed for the EMBARK study. It also adds navigation/label updates such as How to Read a Study Record, Common Questions, How to Join a Study, and updates the Intervention/Treatment label, along with a new Revision: v3.6.0 tag.SummaryDifference0.3%

- Check15 days agoChange DetectedRevision label updated from v3.5.4 to v3.5.5, indicating a new page build.SummaryDifference0.0%

- Check36 days agoChange DetectedA new revision tag v3.5.4 has been added, replacing v3.5.3. This indicates a minor maintenance update to the page's documentation.SummaryDifference0.0%

- Check57 days agoChange DetectedThe page footer has been updated to reflect a newer ClinicalTrials.gov UI/site revision (v3.5.3 instead of v3.5.2). This represents a site maintenance/version change rather than a change to the study details.SummaryDifference0.0%

- Check64 days agoChange DetectedRevision: v3.5.2 replaces v3.5.0.SummaryDifference0.0%

- Check93 days agoChange DetectedAdded the 2026 Neurol Ther publication detailing EMBARK two-year outcomes and updated the revision to v3.5.0; the older online-ahead-of-print citation and its previous revision (v3.4.3) were removed.SummaryDifference0.1%

Stay in the know with updates to Clinical Trial: Delandistrogene in Duchenne Muscular Dystrophy
Enter your email address, and we'll notify you when there's something new on the Clinical Trial: Delandistrogene in Duchenne Muscular Dystrophy page.